TG Therapeutics Q1 2026 Earnings EPS Misses Expectations Despite Stock Gain COE Q3 2025 Earnings Loss per ADS Reported Stock Edges Higher CIMP Q1 2026 Earnings Solid EPS Surprise Amid Steady Operating Performance VSNT Q1 2026 Earnings EPS Surges Past Estimates with 949 Beat MDGL Q1 2026 Earnings EPS Beat Amidst Revenue Ambiguity YETI Q1 2026 Earnings Strong EPS Beat Drives Stock Higher